Sigma Healthcare (SIG.AX) Stock Price
Sigma Healthcare Price
Revenue has compounded at 7.5% per year over the past 19 years to 10.83 B AUD. Earnings per share have grown at 9.9% per year over the last 19 years. Sigma Healthcare's net margin stands at 6.5%, up from -0.2% several years earlier. Sigma Healthcare currently offers a dividend yield of about 0.69%. Analysts set a median price target of 3.46 AUD, implying 28.5% above the current price. Of 17 analysts, 12 rate the stock a buy — an overall Buy consensus.
Sigma Healthcare stock price
Sigma Healthcare business model & stock analysis
Frequently asked questions about Sigma Healthcare
Sigma Healthcare Ltd operates as a leading healthcare distribution company in Australia. With a robust business model, the company focuses on providing comprehensive pharmacy services, wholesale distribution, and retail support to pharmacy customers across the nation. Sigma Healthcare aims to enhance patient health outcomes by ensuring the timely delivery of pharmaceuticals, healthcare products, and related services. By leveraging its extensive network, advanced technology, and strategic partnerships, Sigma Healthcare efficiently manages the supply chain, optimizes inventory, and assists pharmacies in delivering quality healthcare solutions. Through its customer-centric approach and commitment to innovation, Sigma Healthcare upholds its position as a trusted provider in the Australian healthcare industry.
Sigma Healthcare Ltd is primarily active in the pharmaceutical and healthcare industries.
The main competitors of Sigma Healthcare Ltd in the market include Australian Pharmaceutical Industries Limited (API), Ramsay Health Care Limited, and Medibank Private Limited.
Sigma Healthcare Ltd is an Australian pharmacy and healthcare company with a rich history. Established in 1912, Sigma Healthcare has evolved into a leading player in the pharmaceutical industry, providing a wide range of healthcare solutions. The company operates multiple business segments, including wholesale, retail pharmacy, and distribution. It partners with various pharmaceutical manufacturers and suppliers to deliver high-quality products and services to customers. Sigma Healthcare's commitment to innovation, customer satisfaction, and its extensive network of pharmacies has propelled its growth over the years. With a strong presence in the Australian market, Sigma Healthcare Ltd continues to contribute to the nation's healthcare landscape.
Sigma Healthcare Ltd has achieved several significant milestones throughout its history. Some noteworthy achievements include the acquisition of Central Healthcare Services in 2001, which strengthened its position in the pharmacy wholesale market. In 2010, Sigma Healthcare successfully merged with Australian Pharmaceutical Industries, enhancing its capabilities and expanding its reach in the healthcare sector. The company also established SigmaPharm, a state-of-the-art manufacturing facility in 2015, enabling it to produce high-quality generic pharmaceutical products. Furthermore, Sigma Healthcare partnered with Arrow Pharmaceuticals in 2018, forming a strategic alliance that aimed to optimize their respective supply chain networks. These milestones contribute to Sigma Healthcare Ltd's ongoing growth and success in the healthcare industry.
Sigma Healthcare Ltd is primarily present in Australia.
Sigma Healthcare Ltd represents a strong commitment to providing quality healthcare solutions. The company believes in delivering reliable and accessible pharmaceutical products and services to improve patient outcomes. With a customer-centric approach, Sigma Healthcare focuses on building lasting relationships with healthcare providers and stakeholders. The company's corporate philosophy revolves around fostering innovation, collaboration, and integrity within the healthcare industry. Sigma Healthcare aims to create value for its customers and shareholders while ensuring the highest standards of ethical conduct. Through its extensive network and expertise, Sigma Healthcare strives to enhance healthcare delivery and contribute to the well-being of communities.
Analysts currently set an average price target of 3.42 AUD for the Sigma Healthcare stock (median: 3.46 AUD), implying +27.3 % versus the latest price. The consensus is based on 17 analyst ratings.
17 analysts currently rate the Sigma Healthcare stock: 12 recommend buying, 5 holding and 0 selling.
Converted at the current exchange rate, the Sigma Healthcare share trades at 1.67 EUR (2.69 AUD).
The Sigma Healthcare share (SIG.AX) is listed on 3 stock exchanges, including: ASX (SIG.AX), Frankfurt (S5YA.F), Düsseldorf (S5YA.DU).
Sigma Healthcare Ltd is a leading provider of pharmacy products and services in Australia and New Zealand. The company has been operating in the industry for over 100 years and has established itself as a trusted partner for pharmacies and healthcare facilities. The company's business model is based on three main divisions: 1. Wholesale distribution: Sigma Healthcare Ltd's wholesale division offers a wide range of pharmaceutical products, medical devices, consumables, and other health products. The company works closely with pharmacies and healthcare facilities to ensure they have access to the latest and highest quality products. 2. Retail: Sigma Healthcare Ltd also operates a wide range of retail brands, including Amcal, Guardian, and Discount Drug Stores. These brands offer a variety of health products and services, including over-the-counter medications, beauty products, health checks, consultations, and more. 3. Healthcare sector services: Sigma Healthcare Ltd also offers a range of services for the healthcare sector. These include logistics and warehousing services, marketing and advertising services, financial and accounting, information technology, and pharmacy management. The company works closely with healthcare facilities and pharmacies to ensure they operate efficiently and effectively while ensuring high-quality care for their patients. The company offers a wide range of products, including over-the-counter and prescription medications, dietary supplements, medical devices, consumables, hygiene products, beauty products, and more. Sigma Healthcare Ltd collaborates with a variety of international and local manufacturers to ensure they can offer their customers the best products at competitive prices. Innovation plays a key role in Sigma Healthcare Ltd's business model. The company continuously invests in new technologies and systems to ensure it meets the needs of its customers and the healthcare industry. For example, the company recently invested in a new automated warehouse system that has improved the efficiency and accuracy of order processing. Sigma Healthcare Ltd is also committed to playing a leading role in the healthcare sector. The company works closely with government agencies, NGOs, and other organizations to improve the delivery of healthcare services and products. It also has a strong environmental and social responsibility and actively engages in sustainability, workplace safety, community development, and engagement. In conclusion, Sigma Healthcare Ltd is a leading provider of pharmacy products and services in Australia and New Zealand. The company offers a wide range of products and services, including wholesale, retail, and healthcare sector services. Sigma Healthcare Ltd utilizes innovative technologies and systems to operate efficiently and effectively, and to provide its customers with the best health products and services. It also has a strong environmental and social responsibility and actively engages in sustainability and community development.
The revenue of Sigma Healthcare is 10.83 B AUD. This figure is based on current financial data and reflects the company's business performance.
The profit of Sigma Healthcare is 709.18 M AUD. The net profit reflects the company's profitability after deducting all expenses.
The price-to-earnings ratio (P/E) of Sigma Healthcare is currently 43.66. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Sigma Healthcare stock.
The price-to-sales ratio (P/S) of Sigma Healthcare is currently 2.86. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Sigma Healthcare stock.
The Eulerpool Quality Score for Sigma Healthcare is 6/10.
The ISIN of Sigma Healthcare is AU000000SIG5. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of Sigma Healthcare is A2DYWB. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of Sigma Healthcare is SIG.AX. The ticker symbol is used to trade Sigma Healthcare shares on the stock exchange.
Sigma Healthcare stock
Sigma Healthcare Peer Group
Sigma Healthcare Ticker
Sigma Healthcare FIGI
All fundamentals and in-depth analysis of Sigma Healthcare
Our stock analysis for Sigma Healthcare stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Sigma Healthcare. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.